aluates Reports

$ 0.0

Automative

Global Brain Cancer Molecular Diagnostics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-23V5605

Global Brain Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Brain Cancer Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-23V5605

Report

June 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Genetronhealth

Premed

Gene+

DMDbiomed

Helixgen

Annoroad

Geneis

Unitedgene

Inmedi

Qiagen NV

Brain Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Brain Cancer Molecular Diagnostics Market

The global market for Brain Cancer Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A molecular approach for diagnosing brain cancer

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Brain Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Molecular Diagnostics.

The Brain Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Brain Cancer Molecular Diagnostics Market Report

Report Metric	Details
Report Name	Brain Cancer Molecular Diagnostics Market
CAGR	5%
Segment by Type	PCR FISH DNA Sequencing Gene Chip
Segment by Application	Clinical Diagnosis Drug Screening Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Genetronhealth, Premed, Gene+, DMDbiomed, Helixgen, Annoroad, Geneis, Unitedgene, Inmedi, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Molecular Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Brain Cancer Molecular Diagnostics Market report?

Ans: The main players in the Brain Cancer Molecular Diagnostics Market are Genetronhealth, Premed, Gene+, DMDbiomed, Helixgen, Annoroad, Geneis, Unitedgene, Inmedi, Qiagen

What are the Application segmentation covered in the Brain Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Brain Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Brain Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Brain Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 PCR

1.2.3 FISH

1.2.4 DNA Sequencing

1.2.5 Gene Chip

1.3 Market by Application

1.3.1 Global Brain Cancer Molecular Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnosis

1.3.3 Drug Screening

1.3.4 Research

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Brain Cancer Molecular Diagnostics Market Perspective (2020-2031)

2.2 Global Brain Cancer Molecular Diagnostics Growth Trends by Region

2.2.1 Global Brain Cancer Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Brain Cancer Molecular Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Brain Cancer Molecular Diagnostics Market Dynamics

2.3.1 Brain Cancer Molecular Diagnostics Industry Trends

2.3.2 Brain Cancer Molecular Diagnostics Market Drivers

2.3.3 Brain Cancer Molecular Diagnostics Market Challenges

2.3.4 Brain Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue

3.1.1 Global Top Brain Cancer Molecular Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Brain Cancer Molecular Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Brain Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Brain Cancer Molecular Diagnostics Revenue

3.4 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio

3.4.1 Global Brain Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Molecular Diagnostics Revenue in 2024

3.5 Global Key Players of Brain Cancer Molecular Diagnostics Head office and Area Served

3.6 Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application

3.7 Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Cancer Molecular Diagnostics Breakdown Data by Type

4.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031)

5 Brain Cancer Molecular Diagnostics Breakdown Data by Application

5.1 Global Brain Cancer Molecular Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Brain Cancer Molecular Diagnostics Market Size (2020-2031)

6.2 North America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)

6.4 North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Brain Cancer Molecular Diagnostics Market Size (2020-2031)

7.2 Europe Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)

7.4 Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Brain Cancer Molecular Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Brain Cancer Molecular Diagnostics Market Size (2020-2031)

9.2 Latin America Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Brain Cancer Molecular Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genetronhealth

11.1.1 Genetronhealth Company Details

11.1.2 Genetronhealth Business Overview

11.1.3 Genetronhealth Brain Cancer Molecular Diagnostics Introduction

11.1.4 Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.1.5 Genetronhealth Recent Development

11.2 Premed

11.2.1 Premed Company Details

11.2.2 Premed Business Overview

11.2.3 Premed Brain Cancer Molecular Diagnostics Introduction

11.2.4 Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.2.5 Premed Recent Development

11.3 Gene+

11.3.1 Gene+ Company Details

11.3.2 Gene+ Business Overview

11.3.3 Gene+ Brain Cancer Molecular Diagnostics Introduction

11.3.4 Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.3.5 Gene+ Recent Development

11.4 DMDbiomed

11.4.1 DMDbiomed Company Details

11.4.2 DMDbiomed Business Overview

11.4.3 DMDbiomed Brain Cancer Molecular Diagnostics Introduction

11.4.4 DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.4.5 DMDbiomed Recent Development

11.5 Helixgen

11.5.1 Helixgen Company Details

11.5.2 Helixgen Business Overview

11.5.3 Helixgen Brain Cancer Molecular Diagnostics Introduction

11.5.4 Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.5.5 Helixgen Recent Development

11.6 Annoroad

11.6.1 Annoroad Company Details

11.6.2 Annoroad Business Overview

11.6.3 Annoroad Brain Cancer Molecular Diagnostics Introduction

11.6.4 Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.6.5 Annoroad Recent Development

11.7 Geneis

11.7.1 Geneis Company Details

11.7.2 Geneis Business Overview

11.7.3 Geneis Brain Cancer Molecular Diagnostics Introduction

11.7.4 Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.7.5 Geneis Recent Development

11.8 Unitedgene

11.8.1 Unitedgene Company Details

11.8.2 Unitedgene Business Overview

11.8.3 Unitedgene Brain Cancer Molecular Diagnostics Introduction

11.8.4 Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.8.5 Unitedgene Recent Development

11.9 Inmedi

11.9.1 Inmedi Company Details

11.9.2 Inmedi Business Overview

11.9.3 Inmedi Brain Cancer Molecular Diagnostics Introduction

11.9.4 Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.9.5 Inmedi Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Brain Cancer Molecular Diagnostics Introduction

11.10.4 Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025)

11.10.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Genetronhealth

Premed

Gene+

DMDbiomed

Helixgen

Annoroad

Geneis

Unitedgene

Inmedi

Qiagen NV

List of Tables

Table 1. Global Brain Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of PCR

Table 3. Key Players of FISH

Table 4. Key Players of DNA Sequencing

Table 5. Key Players of Gene Chip

Table 6. Global Brain Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Brain Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Brain Cancer Molecular Diagnostics Market Share by Region (2020-2025)

Table 10. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Brain Cancer Molecular Diagnostics Market Share by Region (2026-2031)

Table 12. Brain Cancer Molecular Diagnostics Market Trends

Table 13. Brain Cancer Molecular Diagnostics Market Drivers

Table 14. Brain Cancer Molecular Diagnostics Market Challenges

Table 15. Brain Cancer Molecular Diagnostics Market Restraints

Table 16. Global Brain Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Brain Cancer Molecular Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)

Table 19. Ranking of Global Top Brain Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Brain Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Brain Cancer Molecular Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Brain Cancer Molecular Diagnostics, Product and Application

Table 23. Global Key Players of Brain Cancer Molecular Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Brain Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Brain Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Brain Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Genetronhealth Company Details

Table 49. Genetronhealth Business Overview

Table 50. Genetronhealth Brain Cancer Molecular Diagnostics Product

Table 51. Genetronhealth Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Genetronhealth Recent Development

Table 53. Premed Company Details

Table 54. Premed Business Overview

Table 55. Premed Brain Cancer Molecular Diagnostics Product

Table 56. Premed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Premed Recent Development

Table 58. Gene+ Company Details

Table 59. Gene+ Business Overview

Table 60. Gene+ Brain Cancer Molecular Diagnostics Product

Table 61. Gene+ Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Gene+ Recent Development

Table 63. DMDbiomed Company Details

Table 64. DMDbiomed Business Overview

Table 65. DMDbiomed Brain Cancer Molecular Diagnostics Product

Table 66. DMDbiomed Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 67. DMDbiomed Recent Development

Table 68. Helixgen Company Details

Table 69. Helixgen Business Overview

Table 70. Helixgen Brain Cancer Molecular Diagnostics Product

Table 71. Helixgen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Helixgen Recent Development

Table 73. Annoroad Company Details

Table 74. Annoroad Business Overview

Table 75. Annoroad Brain Cancer Molecular Diagnostics Product

Table 76. Annoroad Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Annoroad Recent Development

Table 78. Geneis Company Details

Table 79. Geneis Business Overview

Table 80. Geneis Brain Cancer Molecular Diagnostics Product

Table 81. Geneis Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Geneis Recent Development

Table 83. Unitedgene Company Details

Table 84. Unitedgene Business Overview

Table 85. Unitedgene Brain Cancer Molecular Diagnostics Product

Table 86. Unitedgene Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Unitedgene Recent Development

Table 88. Inmedi Company Details

Table 89. Inmedi Business Overview

Table 90. Inmedi Brain Cancer Molecular Diagnostics Product

Table 91. Inmedi Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 92. Inmedi Recent Development

Table 93. Qiagen Company Details

Table 94. Qiagen Business Overview

Table 95. Qiagen Brain Cancer Molecular Diagnostics Product

Table 96. Qiagen Revenue in Brain Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Qiagen Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Brain Cancer Molecular Diagnostics Picture

Figure 2. Global Brain Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Brain Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. PCR Features

Figure 5. FISH Features

Figure 6. DNA Sequencing Features

Figure 7. Gene Chip Features

Figure 8. Global Brain Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Brain Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Clinical Diagnosis Case Studies

Figure 11. Drug Screening Case Studies

Figure 12. Research Case Studies

Figure 13. Brain Cancer Molecular Diagnostics Report Years Considered

Figure 14. Global Brain Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Brain Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Brain Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Brain Cancer Molecular Diagnostics Market Share by Players in 2024

Figure 18. Global Top Brain Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Molecular Diagnostics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Brain Cancer Molecular Diagnostics Revenue in 2024

Figure 20. North America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Brain Cancer Molecular Diagnostics Market Share by Region (2020-2031)

Figure 34. China Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Brain Cancer Molecular Diagnostics Market Share by Country (2020-2031)

Figure 46. Turkey Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Brain Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Genetronhealth Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 50. Premed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 51. Gene+ Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 52. DMDbiomed Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 53. Helixgen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 54. Annoroad Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 55. Geneis Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 56. Unitedgene Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 57. Inmedi Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 58. Qiagen Revenue Growth Rate in Brain Cancer Molecular Diagnostics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

Global Liver Cancer Molecular Diagnostics Market Research Report 2024

Global Chest Cancer Molecular Diagnostics Market Research Report 2024

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Kidney Cancer Molecular Diagnostics Market Research Report 2024

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Global Bladder Cancer Molecular Diagnostics Market Research Report 2024

Global Colon Cancer Molecular Diagnostics Market Research Report 2024

Global Laryngeal Cancer Molecular Diagnostics Market Research Report 2024

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Lymphoma Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Gallbladder Cancer Market Research Report 2024

Global Thyroid Cancer Molecular Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions